Asia Pacific PDX Models Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Published Report
  • Jul 2018
  • Asia-Pacific
  • 119 Pages
  • No of Tables: 22
  • No of Figures: 63

Asia Pacific PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand,  Malaysia, Indonesia, Philippines, Rest of APAC) – Industry Trends and Forecast to 2025

Asia Pacific PDX Models Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization. However, due to high cost of PDX models and strict regulations with respect to the utilization of animal models in cancer research are hindering the market growth.

Market Segmentation: Asia Pacific PDX Models Market

  • The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
  • The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
  • The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
  • The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
  • Based on geography, the market is segmented into 11 geographical countries,

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific.

Key Drivers: Asia Pacific PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

Key Points: Asia Pacific PDX Models Market

Charles River is going to dominate the Asia Pacific PDX models market following with Crown Bioscience Inc., Horizon Discovery Group plc, WuXi AppTec, Champion Oncology, Inc., Oncodesign, The Jackson Laboratory, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

  • The mice models segment is dominating the Asia Pacific PDX models market.
  • Respiratory tumor models segment is expected to grow with the highest CAGR of 16.1% in the forecast period 2018 to 2025.

SKU-

LIST OF TABLES ASIA-PACIFIC PDX MODELS MARKET

TABLE 1 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 ASIA-PACIFIC MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 ASIA-PACIFIC RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 ASIA-PACIFIC GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 ASIA-PACIFIC GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 ASIA-PACIFIC RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 ASIA-PACIFIC UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 ASIA-PACIFIC HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 ASIA-PACIFIC OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 ASIA-PACIFIC PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 ASIA-PACIFIC BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 ASIA-PACIFIC PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 ASIA-PACIFIC ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 ASIA PACIFIC PDX MODELS MARKET, BY COUNTRY , 2016 – 2025, (USD MILLION)

TABLE 19 ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 20 ASIA PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 ASIA PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 22 ASIA PACIFIC PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 23 JAPAN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 24 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 JAPAN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 26 JAPAN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 27 CHINA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 28 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 CHINA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 30 CHINA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 31 INDIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 32 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 INDIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 34 INDIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 35 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 36 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 37 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 38 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 39 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 40 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 41 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 42 AUSTRALIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 43 SINGAPORE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 44 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 45 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 46 SINGAPORE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 47 THAILAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 48 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 49 THAILAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 50 THAILAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 51 MALAYSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 52 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 53 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 54 MALAYSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 55 INDONESIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 56 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 57 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 58 INDONESIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 59 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 60 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 61 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 62 PHILIPPINES PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 63 REST OF ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE